BiotechTube
EXO Biologics

EXO Biologics

Gosselies, Belgium· Est.
exobio.be
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

EXO Biologics is a clinical-stage biotech pioneering the development of exosome-based therapeutics and a scalable manufacturing platform. The company employs a triple-axis strategy targeting rare inflammatory diseases, developing a proprietary drug loading technology, and operating a GMP production site to supply high-quality exosomes for internal and external use. It has achieved significant milestones, including initiating the first EMA-approved clinical trial for MSC-derived exosomes and securing substantial Series A funding to advance its pipeline and platform.

Rare Inflammatory Diseases

Technology Platform

Platform for the production, drug loading (with RNAs, proteins, chemical compounds), and GMP manufacturing of exosomes derived from human umbilical cord mesenchymal stromal cells (MSCs).

Funding History

2
Total raised:$10M
Seed$8M
Grant$2M

Opportunities

The vast unmet need in rare diseases (350M patients affected) provides a clear initial target.
The growing exosome therapeutics and drug delivery market offers a significant long-term opportunity, especially with a validated GMP manufacturing and engineering platform that can serve both internal and partner programs.

Risk Factors

Pioneering a novel therapeutic modality carries high technical and regulatory risks, including challenges in manufacturing consistency and defining regulatory pathways.
The company is pre-revenue and will require substantial additional capital, facing competition from numerous other entities in the exosome space.

Competitive Landscape

The exosome therapeutics field is rapidly evolving and highly competitive, with numerous biotech startups (e.g., Codiak BioSciences, Evox Therapeutics), large pharma partners, and academic institutions pursuing similar technologies. Competition focuses on source cells, engineering methods, manufacturing scale, and intellectual property.

More companies in Drug Delivery & Formulation →More companies in Belgium →